Concepedia

Tannaz Armaghany

TA

Statistics

Publications

5

Citations

607

H-Index

5

Active since

2012

Affiliations

Baylor College of Medicine(Current)

University of North Carolina at Chapel Hill

Children's Hospital of Philadelphia

Methodist Hospital

University of Pennsylvania

Tannaz Armaghany is an author at Baylor College of Medicine specializing in oncology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2012–2024

5

Publications

5

Genetic alterations in colorectal cancer.

Tannaz Armaghany, Jon D. Wilson, Quyen Chu et al. · PubMed · 2012 · 378 citations · Full text

, , +14

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

David Steffin, Nisha Ghatwai, Antonino Montalbano et al. · Nature · 2024 · 150 citations · Full text

, , +5

A phase I/II study of TKM-080301, a <i>PLK1</i>-targeted RNAi in patients with adrenocortical cancer (ACC).

Michael J. Demeure, Tannaz Armaghany, Samuel Ejadi et al. · Journal of Clinical Oncology · 2016 · 49 citations

, , +18

A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).

Brandon G. Smaglo, Benjamin Musher, Spyridoula Vasileiou et al. · Journal of Clinical Oncology · 2020 · 15 citations

, , +22

Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers

Andras Heczey, David Steffin, Nisha Ghatwai et al. · 2024 · 15 citations · Full text

1–5 of 5